This invention belongs to the field of
pharmaceutical technology, specifically relating to biomimetic nanomedicines for treating subcutaneous
drug-resistant bacterial infections, their preparation methods, and applications. In this invention,
dopamine hydrochloride is added during the synthesis of a
metal-organic framework to prepare a
dandelion-shaped carbon nanozyme precursor. This precursor is then carbonized to obtain a carbon nanozyme with targeting, photoresponsiveness, and
peroxidase activity. Finally,
berberine hydrochloride is loaded onto the carbon nanozyme to obtain the biomimetic
nanomedicine. The biomimetic
nanomedicine provided by this invention firstly possesses good
biocompatibility; secondly, it has a unique
dandelion-like morphology, which is beneficial for its targeting effect; and finally, it exhibits strong photoresponsiveness in the near-
infrared region, enabling synergistic and efficient bactericidal action through the mechanisms of antibacterial drugs,
photothermal therapy, and chemokinetics. It has significant application value in the preparation of drugs for treating subcutaneous
drug-resistant bacterial infections.